3-179206019-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006218.4(PIK3CA):​c.1145+1431C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.069 in 151,626 control chromosomes in the GnomAD database, including 451 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene PIK3CA is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.069 ( 451 hom., cov: 31)

Consequence

PIK3CA
NM_006218.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.43

Publications

14 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006218.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0968 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006218.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
NM_006218.4
MANE Select
c.1145+1431C>T
intron
N/ANP_006209.2P42336

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3CA
ENST00000263967.4
TSL:2 MANE Select
c.1145+1431C>T
intron
N/AENSP00000263967.3P42336
PIK3CA
ENST00000955190.1
c.1175+1431C>T
intron
N/AENSP00000625249.1
PIK3CA
ENST00000876545.1
c.1145+1431C>T
intron
N/AENSP00000546604.1

Frequencies

GnomAD3 genomes
AF:
0.0691
AC:
10466
AN:
151546
Hom.:
450
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0173
Gnomad AMI
AF:
0.0969
Gnomad AMR
AF:
0.0736
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.0671
Gnomad SAS
AF:
0.0528
Gnomad FIN
AF:
0.0676
Gnomad MID
AF:
0.0353
Gnomad NFE
AF:
0.0988
Gnomad OTH
AF:
0.0686
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0690
AC:
10463
AN:
151626
Hom.:
451
Cov.:
31
AF XY:
0.0675
AC XY:
4998
AN XY:
74048
show subpopulations
African (AFR)
AF:
0.0172
AC:
712
AN:
41300
American (AMR)
AF:
0.0733
AC:
1116
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
371
AN:
3466
East Asian (EAS)
AF:
0.0672
AC:
347
AN:
5160
South Asian (SAS)
AF:
0.0529
AC:
253
AN:
4784
European-Finnish (FIN)
AF:
0.0676
AC:
704
AN:
10416
Middle Eastern (MID)
AF:
0.0313
AC:
9
AN:
288
European-Non Finnish (NFE)
AF:
0.0988
AC:
6715
AN:
67974
Other (OTH)
AF:
0.0703
AC:
148
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
488
976
1465
1953
2441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0838
Hom.:
730
Bravo
AF:
0.0687
Asia WGS
AF:
0.0620
AC:
216
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.61
DANN
Benign
0.48
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2677764;
hg19: chr3-178923807;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.